IDXX: Strong diagnostics growth lifted Q3 results and FY revenue and EPS guidance

What happened

IDXX reported that third-quarter revenue rose 10% and comparable earnings per share, or profit per share adjusted for comparison, increased 22%. Strong diagnostics volume and execution led the results. The company raised its fiscal 2026 revenue and earnings-per-share guidance but reduced its operating margin guidance.

Confirmed

Global impact / market context

Higher revenue and profit-per-share expectations suggest stronger business performance, while the lower operating margin outlook points to less profit from each dollar of revenue than previously expected. If costs absorb more sales, future earnings may not rise as quickly as revenue, despite the upgraded guidance.

Analyst inference

The update combines stronger reported growth and higher full-year revenue and earnings guidance with a reduced operating margin forecast. Investors therefore have to weigh the prospect of more sales and profit per share against the possibility that operating costs will take a larger share of revenue.

Analyst inference

What to watch

1. Future quarterly results can show whether diagnostics volume continues to support revenue growth and whether the company delivers the higher fiscal 2026 revenue and earnings-per-share guidance. Analyst inference
2. The company reduced operating margin guidance, meaning its expected operating profit as a share of revenue fell; watch for any explanation of the change in the supplied reporting. Confirmed
3. Compare revenue growth with operating margin in later reports: if revenue rises while the margin remains lower, costs may be limiting how much sales growth adds to operating profit. Analyst inference

Evidence

• Original source link unavailable